16 States Won't Intervene In FCA Suit Against Compounder

Law360, Nashville (September 25, 2017, 6:08 PM EDT) -- Sixteen states declined Monday to intervene in a whistleblower False Claims Act suit accusing a Florida compounding pharmacy of charging Tricare, Medicare and Medicaid excessively high rates for certain compounded drugs, after the federal government previously intervened in the suit.

After a decision by the federal government to partially intervene in June, and an amended complaint filed by relator McKenzie Stepe in July, the 16 states — represented by Florida — have declined to intervene in the action accusing RS Compounding LLC and current and former...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.